Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04225442
Other study ID # 834156
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 5, 2020
Est. completion date June 4, 2027

Study information

Verified date January 2024
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators piloted the characterization of the human chronobiome. Now, this line of research is extended to explore physiological chronobiome modulated by sex, age and under evoked conditions.


Description:

"Is your body clock important? Absolutely. Just ask any morning lark who lives with a night owl, or vice versa". This quote from a piece published in the Philadelphia Inquirer about the investigator's work illustrates the importance of time in one's personal preferences [https://www.inquirer.com/health/chronobiome-body-clock-university-pennsylvania-20190307.html ]. Several decades of research have found out that how well a person functions, very much depends on how much this person is in harmony with her/his own preferences and environment. This harmony is acutely disturbed when one travels quickly across several time zones, because suddenly the body's physiology is still following the departure time but the arrival time tells the body something different. As a result, travelers often experience sleep problems and indigestion, which usually disappear after a couple of days. This is different in long-term shift workers for whom work outside of the typical daylight hours means that they have a higher risk for diseases including cardiovascular diseases, diabetes and cancer. Another observation has been that many diseases occur or worsen at a specific time of day. Heart attacks, for example, most often occur when patients wake up in the morning. Shortness of breath peaks at 4 am in the morning for patients with asthma. Intriguingly, more and more studies suggest that time of day matters how effective drugs work and how many side effects one might experience. To study this the investigators started to describe the human chronobiome, which foremost looks at time of day differences of a person's physiology, for example, in the small pilot study the investigators saw a difference in break down products, or metabolites, between mornings and evenings. Now, in this present study, the investigators wish to extend the understanding how the human chronobiome differs between healthy men and women, healthy young and old and how it reacts to a fatty meal challenge. This knowledge will help the investigators to say when a finding can still be considered normal or maybe indicates a first sign of disease. The novelty of this approach is that the investigators measure long enough to understand the role of time of day for a person's chronobiome, that the investigators measure many things to obtain a comprehensive representation of a person's chronobiome, that every measure is timestamped, and that the investigators ask participants to eat fatty meals to see how the chronobiome changes.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 48
Est. completion date June 4, 2027
Est. primary completion date January 4, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: 1. Young: 18-30 years of age, Old: 55-75 years of age 2. Apparent healthy 3. BMI (body mass index) up to 27.4 4. Upper arm with intact skin, i.e. without areas of breached or injured skin visible, for ambulatory blood pressure (ABP) measurements, 5. Own and use a smartphone. Exclusion Criteria: 1. History of severe psychiatric illness or cognitive conditions, for example (mania, schizophrenia, or mental retardation; 2. Shift work, defined as recurring work between 22:00-05:00; 3. A diagnosis of clinically significant obstructive sleep apnea; 4. Serum creatinine > 1.5 mg/dl in men or >1.3 mg/del in women; 5. Significant liver disease (>3x upper limit of normal); 6. Diabetes mellitus; 7. Past diagnosis of gastroesophageal reflux disease, 8. Transmeridian travel across =3 time zones in the two weeks before the 48hr deep phenotype sessions; 9. Use of oral or intravenous antibiotics in the 6 months prior to enrollment; 10. Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of = one pint within 8 weeks prior to screening; 11. > 2 drinks of alcohol per day; 12. Use of drugs assessed in the urinary drug test; 13. Nursing or pregnant (pregnancy will be repeatedly assessed at the beginning of each of the four inpatient visits, i.e. prior to the start of blood draws); 14. Use of pacemaker or implantable Cardioverter Defibrillator (ICD); 15. Bilateral mastectomy; 16. History of Raynaud's phenomenon; 17. Known allergy against natural latex rubber (contained in ABP bladder and tubing); 18. Subjects taking medication with alpha-blockers.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fatty meal to challenge the physiological chronobiome in healthy young and old
The intervention consists of a fatty meal

Locations

Country Name City State
United States Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

References & Publications (1)

Skarke C, Lahens NF, Rhoades SD, Campbell A, Bittinger K, Bailey A, Hoffmann C, Olson RS, Chen L, Yang G, Price TS, Moore JH, Bushman FD, Greene CS, Grant GR, Weljie AM, FitzGerald GA. A Pilot Characterization of the Human Chronobiome. Sci Rep. 2017 Dec 7;7(1):17141. doi: 10.1038/s41598-017-17362-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percent difference in the number of proteins with post-translational modifications found in blood samples from young versus old participants High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore what effect age has on the number of proteins with post-translational modifications. 48 hours
Secondary Percent difference in the number of proteins with post-translational modifications found in blood samples from female versus male participants High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore what effect sex has on the number of proteins with post-translational modifications. 48 hours
Secondary Percent difference in the number of proteins with post-translational modifications found in blood samples from female versus male participants and by age High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore whether an interaction between age and sex has an effect on the number of proteins with post-translational modifications. 48 hours
Secondary Percent difference in environmental light exposure between young versus old participants Wrist actigraphy collects personal light exposure 48 hours
Secondary Percent difference in environmental light exposure between young versus old participants and by sex Wrist actigraphy collects personal light exposure 48 hours
Secondary Percent difference in physical activity between young versus old participants Wrist actigraphy records accelerometer data to calculate physical activity 48 hours
Secondary Percent difference in physical activity between young versus old participants and by sex Wrist actigraphy records accelerometer data to calculate physical activity 48 hours
Secondary Percent difference in systolic blood pressure readings between young versus old participants Ambulatory blood pressure measurements (ABPM) collect blood pressure readings 48 hours
Secondary Percent difference in systolic blood pressure readings between young versus old participants and by sex Ambulatory blood pressure measurements (ABPM) collect blood pressure readings 48 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links